To Get Help Now
Click Here
 
Today's Date:

In New York City, an Average of One Passerby per Month is Injured in a Construction Accident

A new Department of Buildings analysis shows that in New York City, an average of one passerby per month is injured in a construction accident.

A Wall Street Journal investigation which focused on passerby injuries, rather than injuries to both construction workers and passersby, found that 96 construction accidents involving passersby occurred between 2008 and 2014, resulting in 155 injuries. More than three-quarters of the accidents happened in Manhattan, according to The Real Deal. More In New York City, an Average of One Passerby per Month is Injured in a Construction Accident

Lawmakers Call on the FDA to ban Amphetamine-like Stimulant Found in Some Dietary Supplements

Lawmakers Call on the FDA to ban Amphetamine-like Stimulant

Lawmakers Call to FDA – ban Amphetamine-like Stimulant


Lawmakers are calling on the U.S. Food and Drug Administration (FDA) to take action against dietary supplement makers who include a potentially dangerous, amphetamine-like stimulant in their products.

BMPEA is an amphetamine-like stimulant first synthesized in the 1930s as a replacement for amphetamine. The chemical has never been tested in humans and is not an authorized dietary supplement ingredient under federal law. Supplement makers have been hiding BMPEA in their products under the name “acacia rigidula,” which is an exotic shrub native to Mexico and southern Texas. Canadian health authorities pulled a popular supplement from store shelves and forced a recall of the product in December, according to The New York Times (The Times.) More Lawmakers Call on the FDA to ban Amphetamine-like Stimulant Found in Some Dietary Supplements

Diabetes Drug Manufacturer Offers $2.2 Billion to Settle Thousands of Lawsuits

Diabetes Drug Manufacturer Offers $2.2B to Settle

Diabetes Drug Manufacturer Offers $2.2B to Settle


The maker of a top diabetes drug that is linked to cancer and other serious health problems has offered to pay more than $2 billion to lay 8,000 lawsuits to rest.

Takeda Pharmaceutical Co., the maker of the drug Actos, has said it will pay $2.2 billion to settle 8,000 lawsuits filed in federal and state courts on behalf of patients who allege that the company hid cancer risks associated with the diabetes medication, court records show. If the offer is accepted, each plaintiff would receive approximately $275,000. More Diabetes Drug Manufacturer Offers $2.2 Billion to Settle Thousands of Lawsuits

Contaminated Duodenoscopes also Linked to Drug-Resistant E. Coli Outbreak

Contaminated Duodenoscopes also Linked to E. Coli Outbreak

Contaminated Duodenoscopes also Linked to E. Coli Outbreak


Tainted duodenoscopes, which have come under scrutiny in light of a series of superbug outbreaks, are also associated with an outbreak of drug-resistant Escherichia coli (E. coli) in a Washington state hospital. According to a study published in Infection Control & Hospital Epidemiology, patients can still be infected even when following manufacturers’ cleaning instructions.

An investigation revealed that between November 2012 and August 2013,32 patients were infected with an antibiotic-resistant strain of E. coli at Seattle Virginia Mason Medical Center. The hospital had followed the manufacturer’s cleaning protocol, but these procedures were apparently insufficient.

Recent evidence suggests that manufacturers’ cleaning instructions alone are not enough to sterilize duodenoscopes, a specialized type of endoscope. Recently, the devices were implicated in recent outbreaks of Carbapenem-resistant Enterobacteriaceae (CRE) at two Los Angeles Hospitals: UCLA’s Ronald Reagan Medical Center and Cedars-Sinai hospital. A total of 11 patients were infected with CRE at the two hospitals and 246 more were potentially exposed.
More Contaminated Duodenoscopes also Linked to Drug-Resistant E. Coli Outbreak

New Deadlines set in Mirena IUD Litigation

New Deadlines set in Mirena IUD Litigation

New Deadlines set in Mirena IUD Litigation


A May 1, 2015 deadline has been set for Bayer Inc. and plaintiffs involved in the Mirena intrauterine device (IUD) litigation to select seven cases to potentially be included in the Second Deposition Pool.

Plaintiffs who wish to have their cases considered for potential inclusion in the Second Deposition Pool must have the Core Criteria in the Plaintiff Fact Sheet completed no later than May 1, 2015, according to a March 17 court order. The Lead Counsel for the Plaintiffs’ Steering Committee (PSC) and Lead Counsel for the Defendants must submit their selections to the court by email by 4:00 p.m. Eastern Standard Time on July 2, 2015. The court order states that these cases should not have unique or idiosyncratic circumstances. Raymond C. Silver, partner at Parker Waichman LLP, has been appointed Co-Lead Counsel in the litigation. More New Deadlines set in Mirena IUD Litigation

Medical Device Maker Facing new Bribery Allegations

Medical Device Maker Facing new Bribery Allegations

Medical Device Maker Facing new Bribery Allegations


Medical device maker Biomet is being investigated by the U.S. Justice Department (D.O.J.) due to fresh bribery allegations.

Prosecutors will extend Biomet’s probation for an additional year, the firm announced earlier this week, in light of recent allegations made by an anonymous whistleblower. According to an email written by the whistleblower, distributors hired by Biomet to sell the company’s orthopedic devices paid kickbacks to government doctors. An internal investigation was launched when Biomet disclosed the email to the government, and several employees at the center of the scandal were fired, according to The New York Times (The Times). More Medical Device Maker Facing new Bribery Allegations

Settlement Deadline Extended for Patients Injured by Defective Stryker Hip Systems

Settlement Deadline Extended for Patients Injured by Stryker

Settlement Deadline Extended for Patients Injured by Stryker


The deadline to enroll in the Stryker Orthopedics Rejuvenate Hip System settlement has been extended to March 30, 2015.

Patients who were implanted with one of the now-recalled ABG II Modular Hip Systems or Rejuvenate Modular Hip Systems still have time to register with the settlement, which was announced in late 2014. More Settlement Deadline Extended for Patients Injured by Defective Stryker Hip Systems

Ice Cream Products Tainted with Listeria Sickens Five People, Killing Three

Ice Cream Products Tainted with Listeria Sickens Five People

Ice Cream Products Tainted w/Listeria Sickens 5 People


Blue Bell ice cream tainted with listeria has sickened five people in Kansas, killing three.

The U.S. Centers for Disease Control and Prevention (CDC) said that five patients who had been “in and out” of a Kansas hospital became infected with listeria bacteria after eating tainted Blue Bell ice cream products while staying at the facility. Four of the patients consumed milkshakes made with a single serving of Blue Bell’s Scoops ice cream, according to the Los Angeles Times (LA Times). More Ice Cream Products Tainted with Listeria Sickens Five People, Killing Three

9/11 First-Responder Diagnosed with Fibromyalgia Wins Fight to Receive Line-of-Duty Pension

9/11 First-Responder Diagnosed w/Fibromyalgia Wins Fight

9/11 First-Responder Diagnosed w/Fibromyalgia Wins Fight


A police officer who served more than 300 hours at Ground Zero in the wake of the September 11, 2001 terror attacks will receive a line-of-duty pension, thanks to a state appeals court ruling.

Annmarie Sheldon was a first responder on 9/11 and served more than 300 hours at the site after the collapse of the World Trade Center (WTC) towers.  She was assigned to a security post a block from Ground Zero on October 4, 2001, when she began experiencing shortness of breath, dizziness, nausea and severe chest pains. The following March, Ms. Sheldon was diagnosed with fibromyalgia. More 9/11 First-Responder Diagnosed with Fibromyalgia Wins Fight to Receive Line-of-Duty Pension

Researchers Link Crohn’s Disease to Oral Contraceptive use

Researchers Link Crohn’s Disease to Oral Contraceptive use

Researchers Link Crohn’s Disease to Oral Contraceptive use


Taking birth control pills for five years or longer may cause Crohn’s disease, an incurable and often debilitating digestive system disease.

Crohn’s is a painful inflammation of the digestive system that is most commonly found in the intestines. Crohn’s patients have difficulty digesting food and suffer from diarrhea, fatigue and anemia. There is no cure for the illness, and it can be so painful that sufferers have been known to commit suicide to escape the agony. At least two Britons have traveled to the controversial Dignitas clinic in Switzerland to end their lives, according to Daily Mail. More Researchers Link Crohn’s Disease to Oral Contraceptive use